|
US20020103145A1
(en)
*
|
1999-05-19 |
2002-08-01 |
Adrian Bot |
Immunization of infants
|
|
US20060014710A9
(en)
*
|
1996-11-22 |
2006-01-19 |
Adrian Bot |
Immunization of infants
|
|
US6391314B1
(en)
*
|
1997-10-03 |
2002-05-21 |
Merial |
Porcine circoviruses vaccines diagnostic reagents
|
|
FR2772047B1
(fr)
|
1997-12-05 |
2004-04-09 |
Ct Nat D Etudes Veterinaires E |
Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
|
|
JP4180238B2
(ja)
|
1997-12-09 |
2008-11-12 |
株式会社コスモ総合研究所 |
環状フェノール硫化物のスルホン酸化合物及びその製造方法
|
|
WO2000025820A1
(en)
*
|
1998-11-04 |
2000-05-11 |
Pharmadigm, Inc. |
Compounds and methods for genetic immunization
|
|
ES2170622B1
(es)
*
|
1999-12-03 |
2004-05-16 |
Consejo Superior De Investigaciones Cientificas |
Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
|
|
DE10014690A1
(de)
*
|
2000-03-24 |
2001-10-18 |
Franz Wolfgang M |
Verfahren zur Isolierung in vito differenzierter Körperzellen
|
|
WO2002072786A2
(en)
|
2001-03-13 |
2002-09-19 |
Corvas International, Inc. |
Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
|
|
AU2002254357A1
(en)
|
2001-03-22 |
2002-10-08 |
Dendreon Corporation |
Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
|
|
CA2442089A1
(en)
|
2001-03-27 |
2002-10-03 |
Dendreon San Diego Llc |
Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
|
|
US7112430B2
(en)
|
2001-05-14 |
2006-09-26 |
Dendreon Corporation |
Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
|
|
EP1390490B1
(en)
*
|
2001-05-24 |
2009-04-15 |
Genzyme Corporation |
Muscle-specific expression vectors
|
|
AU2002357004A1
(en)
*
|
2001-11-20 |
2003-06-10 |
Dendreon San Diego Llc |
Nucleic acid molecules encoding serine protease 17, the encoded polypeptides and methods based thereon
|
|
US20090110702A1
(en)
|
2002-07-12 |
2009-04-30 |
The Johns Hopkins University |
Mesothelin Vaccines and Model Systems and Control of Tumors
|
|
US9200036B2
(en)
|
2002-07-12 |
2015-12-01 |
The Johns Hopkins University |
Mesothelin vaccines and model systems
|
|
CA2492160A1
(en)
*
|
2002-07-12 |
2004-01-22 |
The Johns Hopkins University |
Mesothelin vaccines and model systems
|
|
AU2005249450A1
(en)
|
2004-05-27 |
2005-12-15 |
Centocor, Inc. |
Cynomolgus prostate specific antigen
|
|
CA2570563A1
(en)
*
|
2004-06-15 |
2006-09-28 |
Centocor, Inc. |
Method for screening agents against human prostate disease
|
|
GB201102091D0
(en)
|
2011-02-08 |
2011-03-23 |
Univ Sheffield |
Antigenic polypeptide
|
|
GB201102090D0
(en)
|
2011-02-08 |
2011-03-23 |
Univ Sheffield |
Antigenic polypeptide
|
|
EP3049106A1
(en)
|
2013-09-25 |
2016-08-03 |
Zoetis Services LLC |
Pcv2b divergent vaccine composition and methods of use
|
|
EP3268025B1
(en)
|
2015-03-10 |
2020-05-06 |
University of Massachusetts |
Targeting gdf6 and bmp signaling for anti-melanoma therapy
|
|
ES2977730T3
(es)
|
2016-04-15 |
2024-08-29 |
Res Inst Nationwide Childrens Hospital |
Administración de microARN-29 y micro-distrofina por virus adenoasociado para tratar la distrofia muscular
|
|
EP3596112A2
(en)
|
2017-03-17 |
2020-01-22 |
Newcastle University |
Adeno-associated virus vector delivery of a fragment of micro-dystrophin to treat muscular dystrophy
|
|
MA50836A
(fr)
|
2017-10-18 |
2020-08-26 |
Res Inst Nationwide Childrens Hospital |
Administration par vecteur à virus adéno-associé de micro-dystrophine spécifique de muscles pour traiter la dystrophie musculaire
|
|
MY208145A
(en)
|
2018-06-18 |
2025-04-18 |
Res Inst Nationwide Childrens Hospital |
Adeno-associated virus vector delivery of muscle specific micro-dystrophin to treat muscular dystrophy
|
|
JP7754490B2
(ja)
*
|
2019-11-29 |
2025-10-15 |
学校法人関西医科大学 |
アジュバント組成物
|
|
WO2023008881A1
(ko)
*
|
2021-07-29 |
2023-02-02 |
주식회사 에스엠엘바이오팜 |
발현 시스템 및 이를 포함하는 핵산 기반 약학 조성물
|